008930.KS
008930.KS
KR7008930000
Hanmi Science
Loading chart...

Company Profile

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.

Related stocks

0874.HK
0874.HK • China
BAIYUNSHAN PH
13.21 HKD
2.74B USD 1Y -27.9%
600511.SS
600511.SS • China
CHINA NATIONAL MEDICINES CORP
26.67 CNY
3.01B USD 1Y -7.4%
600739.SS
600739.SS • China
LIAONING CHENGDA
10.33 CNY
2.35B USD 1Y -17%
EBO.NZ
EBO.NZ • Australia
Ebos Group Limited Ordinary Sha
18.98 NZD
2.23B USD 1Y -36.1%
301015.SZ
301015.SZ • China
BAHEAL MEDICAL
25.94 CNY
2.04B USD 1Y -4.5%
1099.HK
1099.HK • China
SINOPHARM
14.87 HKD
5.91B USD 1Y -20.5%
600998.SS
600998.SS • China
JOINTOWN PHARMACEUTICAL GROUP C
5.08 CNY
3.83B USD 1Y +3.3%
600056.SS
600056.SS • China
CHINA MEHECO GROUP CO LTD
9.14 CNY
2.05B USD 1Y -19.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
56.3% p.a.
Max Drawdown (5Y)
-56.8%
Sharpe Ratio (5Y)
-0.05
Beta Factor
0.43
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Elevated Short-Term Volatility: 3Y volatility (62.5%) is noticeably higher than the 5Y average (56.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (56.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.8% in the extended horizon.
ende